Champions Oncology Non-GAAP EPS of $0.01 misses by $0.01, revenue of $14.28M beats by $0.34M

Dec. 13, 2022 4:43 PM ETChampions Oncology, Inc. (CSBR)By: Pranav Ghumatkar, SA News Editor4 Comments
  • Champions Oncology press release (NASDAQ:CSBR): Q2 Non-GAAP EPS of $0.01 misses by $0.01.
  • Revenue of $14.28M (+21.1% Y/Y) beats by $0.34M.
  • Adjusted EBITDA of $686,000
  • Discovery targets progressing along the development timeline; expectation to advance to preclinical phase testing in calendar 2023.

Recommended For You

Comments (4)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.